Bank of America
BIO icon

Bank of America’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bank of America’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,200
Closed -$907K – 8259
2021
Q4 		$907K Buy
+1,200
New +$898K ﹤0.01% 5382

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Bank of America's BIO Position: Q2 2026 in Review

Bank of America increased its Bio-Rad Laboratories Class A (BIO) stake by 10% in Q2 2026, buying an estimated $12.9M and bringing the position to 490,412 shares worth $144M. The position accounts for 0.01% of the portfolio, ranked #954.

Bank of America first reported a position in BIO in Q2 2013 and has held it in 53 quarters since. The position peaked at $285M in Q3 2021. 400 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Bank of America held 490,412 shares of Bio-Rad Laboratories Class A worth $144M as of Q2 2026.
  • Bank of America bought 45,455 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $12.9M.
  • Bio-Rad Laboratories Class A made up 0.01% of Bank of America's portfolio in Q2 2026, its #954 holding.
  • Bank of America first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and has held it in 53 quarters since.
  • Bank of America's Bio-Rad Laboratories Class A position peaked at $285M in Q3 2021.
  • 400 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.